| erythrocyte homeostasis | GO:0034101 | 55 | 0.772 | |
| hematopoietic or lymphoid organ development | GO:0048534 | 191 | 0.632 | |
| hemopoiesis | GO:0030097 | 183 | 0.622 | |
| erythrocyte maturation | GO:0043249 | 8 | 0.463 | |
| cellular response to lipopolysaccharide | GO:0071222 | 3 | 0.448 | |
| immune system process | GO:0002376 | 241 | 0.416 | |
| myeloid cell homeostasis | GO:0002262 | 56 | 0.372 | |
| myeloid cell differentiation | GO:0030099 | 86 | 0.354 | |
| regulation of biosynthetic process | GO:0009889 | 250 | 0.300 | |
| cellular response to biotic stimulus | GO:0071216 | 3 | 0.275 | |
| erythrocyte differentiation | GO:0030218 | 54 | 0.260 | |
| organic cyclic compound metabolic process | GO:1901360 | 301 | 0.234 | |
| immune system development | GO:0002520 | 191 | 0.226 | |
| negative regulation of leukocyte differentiation | GO:1902106 | 1 | 0.215 | |
| cellular macromolecule biosynthetic process | GO:0034645 | 224 | 0.191 | |
| cellular response to chemical stimulus | GO:0070887 | 157 | 0.185 | |
| signal transduction | GO:0007165 | 455 | 0.184 | |
| regulation of cellular biosynthetic process | GO:0031326 | 245 | 0.176 | |
| heterocycle biosynthetic process | GO:0018130 | 215 | 0.176 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 3 | 0.174 | |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 2 | 0.165 | |
| positive regulation of cytokine production | GO:0001819 | 2 | 0.160 | |
| cellular amide metabolic process | GO:0043603 | 4 | 0.151 | |
| cellular nitrogen compound biosynthetic process | GO:0044271 | 218 | 0.151 | |
| response to external stimulus | GO:0009605 | 264 | 0.146 | |
| regulation of primary metabolic process | GO:0080090 | 311 | 0.144 | |
| aromatic compound biosynthetic process | GO:0019438 | 217 | 0.142 | |
| lateral line development | GO:0048882 | 66 | 0.141 | |
| heterocycle metabolic process | GO:0046483 | 290 | 0.136 | |
| regulation of cellular metabolic process | GO:0031323 | 320 | 0.134 | |
| porphyrin containing compound biosynthetic process | GO:0006779 | 8 | 0.127 | |
| cellular transition metal ion homeostasis | GO:0046916 | 3 | 0.127 | |
| organic substance biosynthetic process | GO:1901576 | 289 | 0.126 | |
| cell surface receptor signaling pathway | GO:0007166 | 325 | 0.123 | |
| cellular macromolecule metabolic process | GO:0044260 | 391 | 0.119 | |
| toll like receptor signaling pathway | GO:0002224 | 4 | 0.116 | |
| single organism metabolic process | GO:0044710 | 217 | 0.111 | |
| response to bacterium | GO:0009617 | 58 | 0.111 | |
| specification of symmetry | GO:0009799 | 204 | 0.109 | |
| rna metabolic process | GO:0016070 | 219 | 0.108 | |
| cellular nitrogen compound metabolic process | GO:0034641 | 290 | 0.106 | |
| nucleic acid metabolic process | GO:0090304 | 244 | 0.103 | |
| negative regulation of cytokine production | GO:0001818 | 1 | 0.103 | |
| protein metabolic process | GO:0019538 | 183 | 0.099 | |
| embryonic organ development | GO:0048568 | 381 | 0.099 | |
| negative regulation of biosynthetic process | GO:0009890 | 55 | 0.097 | |
| regulation of nucleic acid templated transcription | GO:1903506 | 213 | 0.094 | |
| heart morphogenesis | GO:0003007 | 156 | 0.094 | |
| cellular biosynthetic process | GO:0044249 | 286 | 0.092 | |
| chemical homeostasis | GO:0048878 | 49 | 0.091 | |
| response to other organism | GO:0051707 | 97 | 0.090 | |
| regulation of gene expression | GO:0010468 | 265 | 0.090 | |
| regulation of rna biosynthetic process | GO:2001141 | 213 | 0.087 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 23 | 0.086 | |
| transition metal ion homeostasis | GO:0055076 | 5 | 0.085 | |
| primitive erythrocyte differentiation | GO:0060319 | 5 | 0.083 | |
| transcription dna templated | GO:0006351 | 181 | 0.083 | |
| cellular aromatic compound metabolic process | GO:0006725 | 295 | 0.083 | |
| regulation of metabolic process | GO:0019222 | 359 | 0.083 | |
| leukocyte proliferation | GO:0070661 | 1 | 0.082 | |
| mononuclear cell proliferation | GO:0032943 | 1 | 0.081 | |
| single organism localization | GO:1902578 | 225 | 0.080 | |
| iron ion homeostasis | GO:0055072 | 4 | 0.080 | |
| erythrocyte development | GO:0048821 | 24 | 0.079 | |
| regulation of macromolecule metabolic process | GO:0060255 | 317 | 0.077 | |
| tube morphogenesis | GO:0035239 | 349 | 0.076 | |
| homeostasis of number of cells | GO:0048872 | 62 | 0.074 | |
| definitive hemopoiesis | GO:0060216 | 18 | 0.074 | |
| regulation of extrinsic apoptotic signaling pathway in absence of ligand | GO:2001239 | 1 | 0.074 | |
| otic placode formation | GO:0043049 | 23 | 0.073 | |
| organic cyclic compound biosynthetic process | GO:1901362 | 223 | 0.073 | |
| macromolecule biosynthetic process | GO:0009059 | 227 | 0.073 | |
| leukocyte differentiation | GO:0002521 | 25 | 0.071 | |
| nitrogen compound metabolic process | GO:0006807 | 319 | 0.071 | |
| nucleobase containing compound biosynthetic process | GO:0034654 | 205 | 0.069 | |
| regulation of nitrogen compound metabolic process | GO:0051171 | 251 | 0.066 | |
| cellular response to external stimulus | GO:0071496 | 2 | 0.065 | |
| positive regulation of transport | GO:0051050 | 2 | 0.064 | |
| osteoclast differentiation | GO:0030316 | 1 | 0.064 | |
| positive regulation of protein complex assembly | GO:0031334 | 2 | 0.061 | |
| negative regulation of nucleic acid templated transcription | GO:1903507 | 45 | 0.061 | |
| ectodermal placode morphogenesis | GO:0071697 | 32 | 0.061 | |
| regulation of cytokine production | GO:0001817 | 3 | 0.060 | |
| organonitrogen compound metabolic process | GO:1901564 | 74 | 0.059 | |
| regulation of protein metabolic process | GO:0051246 | 56 | 0.059 | |
| cellular iron ion homeostasis | GO:0006879 | 3 | 0.059 | |
| single fertilization | GO:0007338 | 3 | 0.057 | |
| central nervous system development | GO:0007417 | 387 | 0.057 | |
| homeostatic process | GO:0042592 | 142 | 0.056 | |
| transcription from rna polymerase ii promoter | GO:0006366 | 80 | 0.056 | |
| nuclear transcribed mrna catabolic process nonsense mediated decay | GO:0000184 | 4 | 0.055 | |
| regulation of macromolecule biosynthetic process | GO:0010556 | 225 | 0.055 | |
| myeloid leukocyte differentiation | GO:0002573 | 15 | 0.054 | |
| larval development | GO:0002164 | 2 | 0.054 | |
| lymphocyte proliferation | GO:0046651 | 1 | 0.054 | |
| metal ion homeostasis | GO:0055065 | 26 | 0.053 | |
| regionalization | GO:0003002 | 274 | 0.053 | |
| peptide metabolic process | GO:0006518 | 1 | 0.053 | |
| translational initiation | GO:0006413 | 3 | 0.052 | |
| otic vesicle morphogenesis | GO:0071600 | 34 | 0.052 | |
| gene expression | GO:0010467 | 252 | 0.052 | |
| determination of bilateral symmetry | GO:0009855 | 204 | 0.052 | |
| stem cell proliferation | GO:0072089 | 4 | 0.051 | |
| extrinsic apoptotic signaling pathway in absence of ligand | GO:0097192 | 1 | 0.051 | |
| response to biotic stimulus | GO:0009607 | 97 | 0.050 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 47 | 0.049 | |
| biosynthetic process | GO:0009058 | 294 | 0.049 | |
| regulation of biological quality | GO:0065008 | 263 | 0.048 | |
| response to organic substance | GO:0010033 | 153 | 0.048 | |
| negative regulation of myeloid cell differentiation | GO:0045638 | 1 | 0.047 | |
| phagocytosis | GO:0006909 | 3 | 0.047 | |
| nucleic acid templated transcription | GO:0097659 | 181 | 0.047 | |
| single organism biosynthetic process | GO:0044711 | 71 | 0.046 | |
| regulation of transcription dna templated | GO:0006355 | 213 | 0.046 | |
| neuron fate determination | GO:0048664 | 2 | 0.046 | |
| regulation of cytokine biosynthetic process | GO:0042035 | 1 | 0.046 | |
| response to carbohydrate | GO:0009743 | 3 | 0.046 | |
| posterior lateral line development | GO:0048916 | 38 | 0.046 | |
| regulation of erythrocyte differentiation | GO:0045646 | 2 | 0.045 | |
| enzyme linked receptor protein signaling pathway | GO:0007167 | 106 | 0.045 | |
| transport | GO:0006810 | 220 | 0.045 | |
| epithelial tube morphogenesis | GO:0060562 | 148 | 0.044 | |
| iron ion transport | GO:0006826 | 4 | 0.044 | |
| heart looping | GO:0001947 | 94 | 0.043 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 9 | 0.042 | |
| antimicrobial humoral response | GO:0019730 | 2 | 0.042 | |
| cellular ketone metabolic process | GO:0042180 | 11 | 0.042 | |
| negative regulation of multicellular organismal process | GO:0051241 | 69 | 0.042 | |
| embryonic organ morphogenesis | GO:0048562 | 274 | 0.041 | |
| primitive hemopoiesis | GO:0060215 | 27 | 0.041 | |
| regulation of cellular macromolecule biosynthetic process | GO:2000112 | 222 | 0.040 | |
| apoptotic process | GO:0006915 | 116 | 0.040 | |
| ectodermal placode development | GO:0071696 | 37 | 0.040 | |
| protein modification process | GO:0036211 | 100 | 0.039 | |
| myeloid cell development | GO:0061515 | 32 | 0.039 | |
| i kappab kinase nf kappab signaling | GO:0007249 | 4 | 0.039 | |
| heme metabolic process | GO:0042168 | 9 | 0.038 | |
| regulation of nucleobase containing compound metabolic process | GO:0019219 | 250 | 0.038 | |
| ion homeostasis | GO:0050801 | 41 | 0.037 | |
| cellular protein metabolic process | GO:0044267 | 129 | 0.036 | |
| maintenance of location | GO:0051235 | 4 | 0.036 | |
| aging | GO:0007568 | 2 | 0.036 | |
| regulation of cell activation | GO:0050865 | 1 | 0.035 | |
| determination of heart left right asymmetry | GO:0061371 | 117 | 0.035 | |
| embryonic skeletal system morphogenesis | GO:0048704 | 93 | 0.035 | |
| negative regulation of gene expression | GO:0010629 | 65 | 0.035 | |
| cation homeostasis | GO:0055080 | 33 | 0.034 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 0 | 0.034 | |
| oxoacid metabolic process | GO:0043436 | 31 | 0.034 | |
| response to stress | GO:0006950 | 263 | 0.034 | |
| eye development | GO:0001654 | 277 | 0.034 | |
| multi organism process | GO:0051704 | 134 | 0.033 | |
| heart process | GO:0003015 | 71 | 0.033 | |
| compound eye development | GO:0048749 | 2 | 0.033 | |
| response to external biotic stimulus | GO:0043207 | 97 | 0.033 | |
| production of molecular mediator of immune response | GO:0002440 | 2 | 0.032 | |
| regulation of cell communication | GO:0010646 | 232 | 0.032 | |
| cellular response to lipid | GO:0071396 | 39 | 0.032 | |
| cellular cation homeostasis | GO:0030003 | 17 | 0.032 | |
| pattern recognition receptor signaling pathway | GO:0002221 | 5 | 0.031 | |
| regulation of wound healing | GO:0061041 | 2 | 0.031 | |
| cellular response to starvation | GO:0009267 | 1 | 0.031 | |
| small molecule metabolic process | GO:0044281 | 77 | 0.031 | |
| cellular response to endogenous stimulus | GO:0071495 | 68 | 0.030 | |
| amide biosynthetic process | GO:0043604 | 1 | 0.030 | |
| cardiac chamber formation | GO:0003207 | 4 | 0.030 | |
| inner ear development | GO:0048839 | 126 | 0.030 | |
| intestinal absorption | GO:0050892 | 2 | 0.030 | |
| fin development | GO:0033333 | 77 | 0.030 | |
| regulation of binding | GO:0051098 | 3 | 0.030 | |
| negative regulation of nitrogen compound metabolic process | GO:0051172 | 59 | 0.030 | |
| positive regulation of stress activated protein kinase signaling cascade | GO:0070304 | 3 | 0.029 | |
| otic vesicle development | GO:0071599 | 42 | 0.029 | |
| regulation of production of molecular mediator of immune response | GO:0002700 | 1 | 0.029 | |
| inner ear morphogenesis | GO:0042472 | 63 | 0.028 | |
| neuromast primordium migration | GO:0048883 | 12 | 0.028 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 3 | 0.027 | |
| signal transduction in absence of ligand | GO:0038034 | 1 | 0.027 | |
| rna biosynthetic process | GO:0032774 | 181 | 0.027 | |
| positive regulation of i kappab kinase nf kappab signaling | GO:0043123 | 3 | 0.027 | |
| single organism transport | GO:0044765 | 206 | 0.027 | |
| death | GO:0016265 | 121 | 0.027 | |
| cardiac atrium morphogenesis | GO:0003209 | 2 | 0.027 | |
| negative regulation of macromolecule metabolic process | GO:0010605 | 76 | 0.026 | |
| lymphatic endothelial cell differentiation | GO:0060836 | 1 | 0.026 | |
| liver development | GO:0001889 | 96 | 0.026 | |
| response to uv | GO:0009411 | 3 | 0.026 | |
| embryonic digestive tract development | GO:0048566 | 4 | 0.025 | |
| connective tissue development | GO:0061448 | 99 | 0.025 | |
| lymphatic endothelial cell fate commitment | GO:0060838 | 1 | 0.025 | |
| vasculature development | GO:0001944 | 278 | 0.025 | |
| lipid storage | GO:0019915 | 1 | 0.025 | |
| regulation of programmed cell death | GO:0043067 | 101 | 0.025 | |
| regulation of multicellular organismal process | GO:0051239 | 277 | 0.024 | |
| cellular amino acid metabolic process | GO:0006520 | 7 | 0.024 | |
| regulation of rna metabolic process | GO:0051252 | 224 | 0.024 | |
| cytokine metabolic process | GO:0042107 | 1 | 0.024 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 7 | 0.024 | |
| regulation of sequestering of calcium ion | GO:0051282 | 4 | 0.024 | |
| embryonic neurocranium morphogenesis | GO:0048702 | 15 | 0.024 | |
| regulation of developmental process | GO:0050793 | 247 | 0.024 | |
| regulation of translation | GO:0006417 | 3 | 0.023 | |
| response to molecule of bacterial origin | GO:0002237 | 14 | 0.023 | |
| nuclear transport | GO:0051169 | 4 | 0.023 | |
| positive regulation of immune effector process | GO:0002699 | 3 | 0.023 | |
| type i interferon production | GO:0032606 | 2 | 0.023 | |
| regulation of tissue remodeling | GO:0034103 | 2 | 0.023 | |
| membrane hyperpolarization | GO:0060081 | 1 | 0.023 | |
| cellular modified amino acid metabolic process | GO:0006575 | 3 | 0.023 | |
| response to glucocorticoid | GO:0051384 | 1 | 0.022 | |
| embryonic cranial skeleton morphogenesis | GO:0048701 | 90 | 0.022 | |
| generation of neurons | GO:0048699 | 385 | 0.022 | |
| ear morphogenesis | GO:0042471 | 64 | 0.022 | |
| regulation of cell death | GO:0010941 | 103 | 0.022 | |
| negative regulation of cellular macromolecule biosynthetic process | GO:2000113 | 48 | 0.021 | |
| negative regulation of extrinsic apoptotic signaling pathway | GO:2001237 | 2 | 0.021 | |
| response to lipid | GO:0033993 | 60 | 0.021 | |
| tissue remodeling | GO:0048771 | 4 | 0.021 | |
| cell migration | GO:0016477 | 237 | 0.021 | |
| regulation of immune effector process | GO:0002697 | 5 | 0.021 | |
| regulation of transcription from rna polymerase ii promoter | GO:0006357 | 114 | 0.021 | |
| negative regulation of chromosome organization | GO:2001251 | 1 | 0.021 | |
| response to amine | GO:0014075 | 1 | 0.021 | |
| determination of left right symmetry | GO:0007368 | 179 | 0.020 | |
| regulation of cellular protein metabolic process | GO:0032268 | 52 | 0.020 | |
| regulation of alternative mrna splicing via spliceosome | GO:0000381 | 1 | 0.020 | |
| cartilage development | GO:0051216 | 96 | 0.020 | |
| gtp metabolic process | GO:0046039 | 4 | 0.020 | |
| lateral line system development | GO:0048925 | 76 | 0.020 | |
| protein localization to nucleus | GO:0034504 | 3 | 0.020 | |
| hepaticobiliary system development | GO:0061008 | 98 | 0.020 | |
| regulation of heart growth | GO:0060420 | 2 | 0.020 | |
| digestive system process | GO:0022600 | 9 | 0.020 | |
| astrocyte differentiation | GO:0048708 | 1 | 0.020 | |
| retina development in camera type eye | GO:0060041 | 146 | 0.020 | |
| regulation of signaling | GO:0023051 | 235 | 0.020 | |
| ventricular cardiac muscle tissue development | GO:0003229 | 3 | 0.019 | |
| peptide transport | GO:0015833 | 1 | 0.019 | |
| ventricular cardiac muscle tissue morphogenesis | GO:0055010 | 2 | 0.019 | |
| locomotion | GO:0040011 | 313 | 0.019 | |
| cardiac chamber development | GO:0003205 | 19 | 0.019 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 0 | 0.019 | |
| hormone secretion | GO:0046879 | 2 | 0.019 | |
| embryonic limb morphogenesis | GO:0030326 | 2 | 0.019 | |
| positive regulation of cellular catabolic process | GO:0031331 | 3 | 0.019 | |
| inorganic ion transmembrane transport | GO:0098660 | 57 | 0.019 | |
| translation | GO:0006412 | 5 | 0.019 | |
| embryonic viscerocranium morphogenesis | GO:0048703 | 52 | 0.018 | |
| epithelial cell differentiation | GO:0030855 | 116 | 0.018 | |
| embryonic heart tube development | GO:0035050 | 133 | 0.018 | |
| dorsal ventral pattern formation | GO:0009953 | 125 | 0.018 | |
| b cell activation | GO:0042113 | 2 | 0.018 | |
| regulation of myeloid cell differentiation | GO:0045637 | 8 | 0.018 | |
| regulation of translational initiation | GO:0006446 | 1 | 0.018 | |
| respiratory burst | GO:0045730 | 2 | 0.018 | |
| positive regulation of biosynthetic process | GO:0009891 | 68 | 0.017 | |
| innate immune response activating signal transduction | GO:0002758 | 5 | 0.017 | |
| ventricular cardiac muscle cell differentiation | GO:0055012 | 6 | 0.017 | |
| regulation of signal transduction | GO:0009966 | 225 | 0.017 | |
| regulation of bone remodeling | GO:0046850 | 2 | 0.017 | |
| cellular response to organic substance | GO:0071310 | 105 | 0.017 | |
| skeletal system development | GO:0001501 | 181 | 0.017 | |
| regulation of protein complex assembly | GO:0043254 | 3 | 0.017 | |
| cellular protein modification process | GO:0006464 | 100 | 0.017 | |
| embryonic pectoral fin morphogenesis | GO:0035118 | 24 | 0.017 | |
| negative regulation of nucleobase containing compound metabolic process | GO:0045934 | 59 | 0.017 | |
| regulation of transcription from rna polymerase iii promoter | GO:0006359 | 1 | 0.017 | |
| proteasomal protein catabolic process | GO:0010498 | 2 | 0.017 | |
| cell death | GO:0008219 | 121 | 0.017 | |
| heart valve formation | GO:0003188 | 4 | 0.016 | |
| stem cell maintenance | GO:0019827 | 4 | 0.016 | |
| protein targeting to nucleus | GO:0044744 | 3 | 0.016 | |
| granulocyte differentiation | GO:0030851 | 8 | 0.016 | |
| regulation of myeloid leukocyte differentiation | GO:0002761 | 5 | 0.016 | |
| response to lipopolysaccharide | GO:0032496 | 13 | 0.016 | |
| regulation of response to stimulus | GO:0048583 | 269 | 0.016 | |
| anterior posterior pattern specification | GO:0009952 | 152 | 0.016 | |
| programmed cell death | GO:0012501 | 119 | 0.016 | |
| response to endogenous stimulus | GO:0009719 | 83 | 0.016 | |
| peripheral nervous system development | GO:0007422 | 55 | 0.016 | |
| guanosine containing compound metabolic process | GO:1901068 | 4 | 0.016 | |
| carbohydrate homeostasis | GO:0033500 | 1 | 0.016 | |
| sensory system development | GO:0048880 | 76 | 0.016 | |
| cellular response to extracellular stimulus | GO:0031668 | 2 | 0.016 | |
| multicellular organism growth | GO:0035264 | 4 | 0.016 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 0 | 0.016 | |
| regulation of protein transport | GO:0051223 | 3 | 0.016 | |
| embryonic hemopoiesis | GO:0035162 | 53 | 0.015 | |
| appendage development | GO:0048736 | 80 | 0.015 | |
| neuromast development | GO:0048884 | 46 | 0.015 | |
| negative regulation of macromolecule biosynthetic process | GO:0010558 | 48 | 0.015 | |
| sensory organ development | GO:0007423 | 393 | 0.015 | |
| interferon beta production | GO:0032608 | 1 | 0.015 | |
| neuron neuron synaptic transmission | GO:0007270 | 1 | 0.015 | |
| cellular ion homeostasis | GO:0006873 | 17 | 0.015 | |
| negative regulation of nuclear division | GO:0051784 | 3 | 0.015 | |
| embryonic heart tube morphogenesis | GO:0003143 | 108 | 0.015 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 1 | 0.015 | |
| regulation of neurotransmitter transport | GO:0051588 | 1 | 0.015 | |
| organic acid metabolic process | GO:0006082 | 31 | 0.015 | |
| negative regulation of cellular process | GO:0048523 | 283 | 0.015 | |
| sequestering of metal ion | GO:0051238 | 3 | 0.015 | |
| retina morphogenesis in camera type eye | GO:0060042 | 79 | 0.015 | |
| cellular response to stress | GO:0033554 | 62 | 0.015 | |
| megakaryocyte differentiation | GO:0030219 | 1 | 0.015 | |
| regulation of cellular amine metabolic process | GO:0033238 | 0 | 0.015 | |
| negative regulation of biological process | GO:0048519 | 304 | 0.015 | |
| b cell mediated immunity | GO:0019724 | 3 | 0.015 | |
| regulation of response to biotic stimulus | GO:0002831 | 2 | 0.014 | |
| retinoic acid receptor signaling pathway | GO:0048384 | 16 | 0.014 | |
| system process | GO:0003008 | 185 | 0.014 | |
| cellular response to retinoic acid | GO:0071300 | 1 | 0.014 | |
| endothelial cell fate commitment | GO:0060839 | 3 | 0.014 | |
| positive regulation of innate immune response | GO:0045089 | 8 | 0.014 | |
| defense response | GO:0006952 | 47 | 0.014 | |
| atrioventricular valve formation | GO:0003190 | 3 | 0.014 | |
| proteasome mediated ubiquitin dependent protein catabolic process | GO:0043161 | 2 | 0.014 | |
| neurotransmitter secretion | GO:0007269 | 2 | 0.014 | |
| transition metal ion transport | GO:0000041 | 6 | 0.014 | |
| regulation of blood coagulation | GO:0030193 | 1 | 0.014 | |
| positive regulation of macromolecule biosynthetic process | GO:0010557 | 59 | 0.014 | |
| nuclear import | GO:0051170 | 3 | 0.014 | |
| positive regulation of map kinase activity | GO:0043406 | 3 | 0.014 | |
| positive regulation of wound healing | GO:0090303 | 1 | 0.014 | |
| autophagy | GO:0006914 | 4 | 0.014 | |
| negative regulation of cellular biosynthetic process | GO:0031327 | 55 | 0.014 | |
| negative regulation of mitosis | GO:0045839 | 3 | 0.014 | |
| cell projection organization | GO:0030030 | 284 | 0.014 | |
| single organism nuclear import | GO:1902593 | 3 | 0.014 | |
| positive regulation of translation | GO:0045727 | 1 | 0.013 | |
| establishment of protein localization to organelle | GO:0072594 | 4 | 0.013 | |
| activation of innate immune response | GO:0002218 | 6 | 0.013 | |
| nucleocytoplasmic transport | GO:0006913 | 4 | 0.013 | |
| cardiac atrium development | GO:0003230 | 4 | 0.013 | |
| immunoglobulin mediated immune response | GO:0016064 | 3 | 0.013 | |
| regulation of myelination | GO:0031641 | 1 | 0.013 | |
| positive regulation of camp metabolic process | GO:0030816 | 2 | 0.013 | |
| rhombomere 5 development | GO:0021571 | 4 | 0.013 | |
| regulation of protein binding | GO:0043393 | 3 | 0.013 | |
| positive regulation of nucleobase containing compound metabolic process | GO:0045935 | 69 | 0.013 | |
| regulation of cardiac muscle tissue development | GO:0055024 | 1 | 0.013 | |
| phosphorus metabolic process | GO:0006793 | 109 | 0.013 | |
| mechanosensory lateral line system development | GO:0048881 | 49 | 0.013 | |
| positive regulation of type i interferon production | GO:0032481 | 1 | 0.013 | |
| regulation of establishment of protein localization | GO:0070201 | 4 | 0.013 | |
| ear development | GO:0043583 | 127 | 0.013 | |
| regulation of protein targeting | GO:1903533 | 2 | 0.013 | |
| endocardium formation | GO:0060214 | 1 | 0.013 | |
| negative regulation of programmed cell death | GO:0043069 | 58 | 0.013 | |
| neurotransmitter transport | GO:0006836 | 2 | 0.013 | |
| lymph vessel morphogenesis | GO:0036303 | 25 | 0.013 | |
| regulation of response to external stimulus | GO:0032101 | 31 | 0.013 | |
| pectoral fin development | GO:0033339 | 50 | 0.013 | |
| negative regulation of cellular metabolic process | GO:0031324 | 77 | 0.013 | |
| midbrain development | GO:0030901 | 28 | 0.012 | |
| embryonic skeletal system development | GO:0048706 | 97 | 0.012 | |
| regulation of stem cell differentiation | GO:2000736 | 4 | 0.012 | |
| mitochondrion organization | GO:0007005 | 4 | 0.012 | |
| calcium ion homeostasis | GO:0055074 | 19 | 0.012 | |
| regulation of reproductive process | GO:2000241 | 4 | 0.012 | |
| cellular response to nutrient levels | GO:0031669 | 2 | 0.012 | |
| somatic stem cell maintenance | GO:0035019 | 1 | 0.012 | |
| positive regulation of canonical wnt signaling pathway | GO:0090263 | 4 | 0.012 | |
| ribosomal small subunit biogenesis | GO:0042274 | 2 | 0.012 | |
| endocardium morphogenesis | GO:0003160 | 4 | 0.012 | |
| regulation of i kappab kinase nf kappab signaling | GO:0043122 | 4 | 0.012 | |
| positive regulation of cellular metabolic process | GO:0031325 | 94 | 0.012 | |
| positive regulation of programmed cell death | GO:0043068 | 29 | 0.012 | |
| negative regulation of myeloid leukocyte differentiation | GO:0002762 | 1 | 0.012 | |
| positive regulation of jnk cascade | GO:0046330 | 3 | 0.012 | |
| embryonic heart tube formation | GO:0003144 | 1 | 0.012 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 50 | 0.012 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 3 | 0.012 | |
| regulation of protein modification by small protein conjugation or removal | GO:1903320 | 3 | 0.012 | |
| response to corticosteroid | GO:0031960 | 1 | 0.012 | |
| regulation of apoptotic process | GO:0042981 | 98 | 0.012 | |
| positive regulation of response to stimulus | GO:0048584 | 80 | 0.012 | |
| negative regulation of cell death | GO:0060548 | 60 | 0.012 | |
| otic vesicle formation | GO:0030916 | 27 | 0.012 | |
| cardiac ventricle development | GO:0003231 | 9 | 0.012 | |
| actin polymerization or depolymerization | GO:0008154 | 2 | 0.012 | |
| negative regulation of rna metabolic process | GO:0051253 | 48 | 0.012 | |
| internal protein amino acid acetylation | GO:0006475 | 2 | 0.012 | |
| positive regulation of cell activation | GO:0050867 | 1 | 0.012 | |
| organelle organization | GO:0006996 | 227 | 0.012 | |
| positive regulation of cytosolic calcium ion concentration | GO:0007204 | 4 | 0.012 | |
| regulation of chromosome segregation | GO:0051983 | 1 | 0.011 | |
| nucleobase containing compound metabolic process | GO:0006139 | 274 | 0.011 | |
| regulation of neuron migration | GO:2001222 | 2 | 0.011 | |
| cellular response to hormone stimulus | GO:0032870 | 39 | 0.011 | |
| camera type eye development | GO:0043010 | 222 | 0.011 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 4 | 0.011 | |
| septum transversum development | GO:0003343 | 4 | 0.011 | |
| pectoral fin morphogenesis | GO:0035138 | 29 | 0.011 | |
| humoral immune response mediated by circulating immunoglobulin | GO:0002455 | 3 | 0.011 | |
| positive regulation of biological process | GO:0048518 | 253 | 0.011 | |
| protein import | GO:0017038 | 3 | 0.011 | |
| regulation of gtp catabolic process | GO:0033124 | 2 | 0.011 | |
| response to amphetamine | GO:0001975 | 1 | 0.011 | |
| heart valve development | GO:0003170 | 14 | 0.011 | |
| ectodermal placode formation | GO:0060788 | 26 | 0.011 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 3 | 0.011 | |
| regulation of cell differentiation | GO:0045595 | 142 | 0.011 | |
| purine nucleotide biosynthetic process | GO:0006164 | 20 | 0.011 | |
| regulation of protein import into nucleus | GO:0042306 | 2 | 0.011 | |
| regulation of multicellular organismal development | GO:2000026 | 223 | 0.011 | |
| regulation of leukocyte mediated immunity | GO:0002703 | 1 | 0.011 | |
| response to hexose | GO:0009746 | 3 | 0.011 | |
| regulation of localization | GO:0032879 | 104 | 0.011 | |
| cardiac chamber morphogenesis | GO:0003206 | 12 | 0.011 | |
| divalent inorganic cation homeostasis | GO:0072507 | 22 | 0.011 | |
| regulation of molecular function | GO:0065009 | 70 | 0.011 | |
| negative regulation of cell differentiation | GO:0045596 | 46 | 0.011 | |
| positive regulation of secretion | GO:0051047 | 1 | 0.011 | |
| cell cycle g1 s phase transition | GO:0044843 | 1 | 0.011 | |
| cellular response to oxygen levels | GO:0071453 | 1 | 0.011 | |
| protein acylation | GO:0043543 | 3 | 0.011 | |
| neural retina development | GO:0003407 | 49 | 0.011 | |
| establishment of rna localization | GO:0051236 | 3 | 0.011 | |
| regulation of body fluid levels | GO:0050878 | 16 | 0.011 | |
| response to wounding | GO:0009611 | 116 | 0.010 | |
| cellular metal ion homeostasis | GO:0006875 | 16 | 0.010 | |
| cytosolic calcium ion transport | GO:0060401 | 3 | 0.010 | |
| heart valve morphogenesis | GO:0003179 | 8 | 0.010 | |
| regulation of bone mineralization | GO:0030500 | 2 | 0.010 | |
| negative regulation of multi organism process | GO:0043901 | 3 | 0.010 | |
| positive regulation of peptidyl tyrosine phosphorylation | GO:0050731 | 1 | 0.010 | |
| regulation of nucleocytoplasmic transport | GO:0046822 | 2 | 0.010 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 2 | 0.010 | |
| regulation of circadian rhythm | GO:0042752 | 4 | 0.010 | |
| positive regulation of cellular process | GO:0048522 | 201 | 0.010 | |
| regulation of immune system process | GO:0002682 | 34 | 0.010 | |
| positive regulation of immune system process | GO:0002684 | 17 | 0.010 | |
| response to monosaccharide | GO:0034284 | 3 | 0.010 | |
| mitotic cytokinesis | GO:0000281 | 3 | 0.010 | |
| positive regulation of secretion by cell | GO:1903532 | 1 | 0.010 | |
| endothelium development | GO:0003158 | 25 | 0.010 | |
| regulation of immune response | GO:0050776 | 14 | 0.010 | |
| regulation of fatty acid metabolic process | GO:0019217 | 1 | 0.010 | |
| response to oxygen containing compound | GO:1901700 | 55 | 0.010 | |
